Physician profile
Alyssa Larimore
NPI 1841411345
$937.79
in general payments reported to CMS, 2019-2025
16 companies · $16.33 in 2025
The $16.33 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $289 · 2023: $128 · 2024: $254 · 2025: $16.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.30 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $229.98 | 2021-2022 | |
| Therapeuticsmd, INC. | $152.62 | 2021-2022 | |
| Daiichi Sankyo INC. | $109.03 | 2023-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $99.73 | 2022-2024 | |
| Axonics, INC. | $50.53 | 2023-2024 | Axonics |
| Millicent US INC | $46.42 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $40.43 | 2021-2024 | Summit Doppler |
| Astellas Pharma US INC | $36.24 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $35.29 | 2023-2024 | |
| Scynexis, INC. | $28.82 | 2022 | |
| Aspira Women'S Health INC | $28.47 | 2022 | |
| Mylan Pharmaceuticals INC. | $21.22 | 2022 | |
| Avion Pharmaceuticals | $19.96 | 2021 | |
| Exeltis, USA INC. | $18.14 | 2024 | Slynd |
| Medtronic, INC. | $16.58 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $4.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Larimore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.